Combating infectious diseases and the threat of antimicrobial resistance remains one of the greatest global challenges.
COVID-19 vaccinations that combine two or more distinct variants of the SARS-CoV-2 virus could offer protection against both current and future ‘...
Cambridge scientists have identified a drug that can be repurposed to prevent COVID-19 in research involving a unique mix of ‘mini-organs’, donor...
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being...
Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the...
Cambridge is among 12 institutions across the UK that will be working together to tackle the monkeypox outbreak, developing better diagnostic tests...
Referrals to Cambridge’s long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the...
First ancient herpes genomes to be sequenced suggest a Bronze Age flourishing linked to migrations into Europe and possibly the emergence of kissing.
Scientists say continuous monitoring of the cholera bug genome is key to preventing outbreaks of new variants.
A new study has found that a highly antibiotic-resistant strain of the superbug MRSA – methicillin resistant Staphylococcus aureus – has emerged in...
Scientists evaluate the evidence that intensive livestock farming is causing pandemics, and find that intensive farming could actually reduce the...
Scientists have released the first real-world data from Africa on the effectiveness of two doses of AstraZeneca/ChaAd0x-1 COVID-19 vaccination...
Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42 million (about £32 million...
